• Mifepristone: a drug approved by the FDA to end an early pregnancy that can be ingested by an individual on their own time, in their own space.
• The issue: a longstanding FDA rule requires providers to be in the same place as patients seeking mifepristone, causing those seeking the medication in traditional settings to struggle to find providers nearby and adding an extra layer of danger due to the pandemic.
• The good news: the FDA suspended this rule as of 4/12/21, allowing clinicians to prescribe via telehealth (i.e. during long-distance visits using video calls).
• Our task: petition the Biden-Harris Administration to permanently end the restriction and allow remote prescriptions and mail delivery of abortion medication.
The Food and Drug Administration (FDA) just suspended its enforcement of the in-person dispensing requirement for mifepristone throughout the remainder of the COVID-19 public health emergency. This important victory for reproductive freedom means that, in states where the practice is not specifically prohibited, a clinician can now prescribe mifepristone via telehealth and the abortion medication can be delivered by mail.
No one should be forced to risk unnecessary exposure to COVID-19 — jeopardizing their health and life and that of their family and community — by traveling to a hospital or clinic to pick up abortion medication in person, a requirement that is not imposed on any of the other more than 20,000 FDA-approved drugs. Permanently ending the in-person dispensing requirement for mifepristone is not only consistent with scientific and medical evidence, but will improve access, particularly for the people of color, people who live in rural areas, and those struggling to make ends meet who are disproportionately impacted by this medically unnecessary abortion restriction.
Help us move closer to a world where every person is able to access comprehensive, affordable, compassionate, and equitable abortion care in whatever setting they choose and at whatever time they choose. Add your name below to thank the Biden-Harris administration for their work to lift the in-person dispensing requirement during the pandemic and to urge the FDA to do so permanently.
Sign the petition below to the Biden-Harris administration: The FDA must permanently end the in-person dispensing requirement for mifepristone.